Diane E. Wilfong - 12 Mar 2025 Form 3 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Interim Corp Controller & CAO
Signature
/s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Issuer symbol
GILD
Transactions as of
12 Mar 2025
Net transactions value
$0
Form type
3
Filing time
20 Mar 2025, 17:42:55 UTC
Previous filing
09 Apr 2024
Next filing
11 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GILD Common Stock 45,096 12 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GILD Non-qualified Stock Option (Right to Buy) 12 Mar 2025 Common Stock 1,070 $63.91 Direct F1
holding GILD Non-qualified Stock Option (Right to Buy) 12 Mar 2025 Common Stock 5,891 $57.92 Direct F1
holding GILD Non-qualified Stock Option (Right to Buy) 12 Mar 2025 Common Stock 6,560 $75.12 Direct F1
holding GILD Non-qualified Stock Option (Right to Buy) 12 Mar 2025 Common Stock 5,403 $79.50 Direct F1
holding GILD Non-qualified Stock Option (Right to Buy) 12 Mar 2025 Common Stock 5,240 $117.21 Direct F1
holding GILD Restricted Stock Unit 12 Mar 2025 Common Stock 9,705 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.